- Home
- OXY vs SBFM Comparison
OXY vs SBFM Comparison
Compare OXY & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXY
- SBFM
- Stock Information
- Founded
- OXY 1920
- SBFM 2006
- Country
- OXY United States
- SBFM United States
- Employees
- OXY N/A
- SBFM N/A
- Industry
- OXY Oil & Gas Production
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- OXY Energy
- SBFM Health Care
- Exchange
- OXY Nasdaq
- SBFM Nasdaq
- Market Cap
- OXY N/A
- SBFM 4.9M
- IPO Year
- OXY N/A
- SBFM N/A
- Fundamental
- Price
- OXY $42.16
- SBFM $1.25
- Analyst Decision
- OXY Hold
- SBFM Strong Buy
- Analyst Count
- OXY 19
- SBFM 1
- Target Price
- OXY $52.39
- SBFM $15.00
- AVG Volume (30 Days)
- OXY 11.0M
- SBFM 788.6K
- Earning Date
- OXY 05-07-2025
- SBFM 05-19-2025
- Dividend Yield
- OXY 2.28%
- SBFM N/A
- EPS Growth
- OXY N/A
- SBFM N/A
- EPS
- OXY 2.47
- SBFM N/A
- Revenue
- OXY $27,553,000,000.00
- SBFM $34,874,283.00
- Revenue This Year
- OXY $4.33
- SBFM $192.48
- Revenue Next Year
- OXY $4.13
- SBFM N/A
- P/E Ratio
- OXY $17.08
- SBFM N/A
- Revenue Growth
- OXY 2.02
- SBFM 44.75
- 52 Week Low
- OXY $34.78
- SBFM $1.17
- 52 Week High
- OXY $64.76
- SBFM $23.20
- Technical
- Relative Strength Index (RSI)
- OXY 54.23
- SBFM 36.33
- Support Level
- OXY $38.72
- SBFM $1.24
- Resistance Level
- OXY $39.85
- SBFM $1.45
- Average True Range (ATR)
- OXY 1.08
- SBFM 0.12
- MACD
- OXY 0.50
- SBFM 0.01
- Stochastic Oscillator
- OXY 95.16
- SBFM 10.26
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.